Issue navigation
Volume 110, Issue 4, April 2018
Editorial
Retuning the Radio in Radiobiology
Steven J Chmura and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 325–326, https://doi.org/10.1093/jnci/djx234
Thyroid Cancer: Is It All in the Genes?
Electron Kebebew
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 327–328, https://doi.org/10.1093/jnci/djx210
Reviews
The Future of Radiobiology
David G Kirsch and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 329–340, https://doi.org/10.1093/jnci/djx231
Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review
Vivek Verma and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 341–353, https://doi.org/10.1093/jnci/djx208
Articles
International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
Joannie Lortet-Tieulent and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 354–361, https://doi.org/10.1093/jnci/djx214
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Yueye Huang and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 362–370, https://doi.org/10.1093/jnci/djx227
Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer
Alexey A Efanov and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 371–378, https://doi.org/10.1093/jnci/djx209
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer
Yu Xiang and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 379–389, https://doi.org/10.1093/jnci/djx223
Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression
David Sánchez-Martín and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 390–399, https://doi.org/10.1093/jnci/djx219
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Hee-Joo Choi and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 400–410, https://doi.org/10.1093/jnci/djx207
Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study
Yin Ting Cheung and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 411–419, https://doi.org/10.1093/jnci/djx224
Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance
James R Broughman and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 420–425, https://doi.org/10.1093/jnci/djx218
Brief Communication
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status
Matteo Lambertini and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 426–429, https://doi.org/10.1093/jnci/djx206
Correspondence
RE: Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival
Jens Overgaard
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 430–431, https://doi.org/10.1093/jnci/djx229
RE: Proportion of Never-Smoker Non–Small Cell Lung Cancer Patients at Three Diverse Institutions
Barbara J Page and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Page 432, https://doi.org/10.1093/jnci/djx216
Response
Trevor J Bledsoe and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Pages 433–434, https://doi.org/10.1093/jnci/djx230
Response
Lorraine Pelosof and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Page 435, https://doi.org/10.1093/jnci/djx217
Corrigendum
Corrigendum to “Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients”
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Page 436, https://doi.org/10.1093/jnci/djy020
Errata
Erratum to “Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors”
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Page 437, https://doi.org/10.1093/jnci/djy016
Erratum to “Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival”
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 4, April 2018, Page 438, https://doi.org/10.1093/jnci/djy034
Advertisement
Advertisement